Oncology Institute Inc/The

$6.59 0.00% ($0.00)
  • 1D
  • 1W
  • 1M
  • 1Y
  • 5Y
  • YTD

Get ready to invest


About Oncology Institute Inc/The

The Oncology Institute, Inc., formerly DFP Healthcare Acquisitions Corp., is an oncology company. The Company manages community-based oncology practices that serve patients at approximately 55 clinic locations across eight markets and four states throughout the United States. The Company’s managed clinics provide a range of medical oncology services, including physician services, in-house infusion and dispensary, clinical trial services, programs like outpatient stem cell transplants and transfusions, along with 24/7 patient support. Through the Innovative Clinical Research Institute (ICRI), the Company also provides and manages clinical trial services and research for the benefit of cancer patients. Its services, such as managing clinical trials, palliative care programs and stem cell transplants, are accessed through academic and tertiary care settings. Its managed clinics primarily serve adult and senior cancer patients in markets that have Medicare Advantage (MA) plans.

Stock Analysis

last close $6.61
1-mo return 16.6%
3-mo return -32.8%
avg daily vol. 39.72T
52-week high 12.66
52-week low 3.75
market cap. $492M
forward pe -
annual div. -
roe -16.5%
ltg forecast -
dividend yield -
annual rev. $210M
inst own. 71.8%

Subscribe now for daily local and international financial news